Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer

The addition of adjuvant trastuzumab therapy for 1 year to standard chemotherapy significantly improved disease-free survival and overall survival versus chemotherapy alone in a number of pivotal early breast cancer studies. Here we review long-term follow-up data on the efficacy, cardiac safety, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristeleit, Hartmut, Parton, Marina, Beresford, Mark, Macpherson, Iain R., Sharma, Rajan, Lazarus, Loren, Kelleher, Muireann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054055/
https://www.ncbi.nlm.nih.gov/pubmed/27181019
http://dx.doi.org/10.1007/s11523-016-0438-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054055/
https://www.ncbi.nlm.nih.gov/pubmed/27181019
http://dx.doi.org/10.1007/s11523-016-0438-5

Ejemplares similares